journal article·2022-03-11Open access

Investigating Cancerous Exosomes’ Effects on CD8+ T-Cell IL-2 Production in a 3D Unidirectional Flow Bioreactor Using 3D Printed, RGD-Functionalized PLLA Scaffolds

Daniel Karami, Akhil Srivastava, Rajagopal Ramesh, Vassilios I. Sikavitsas

Abstract

Exosomes from cancer cells are implicated in cancer progression and metastasis, carrying immunosuppressive factors that limit the antitumor abilities of immune cells. The development of a real-time, 3D cell/scaffold construct flow perfusion system has been explored as a novel tool in the study of T-cells and exosomes from cancer cells. Exosomes from human lung cancer (H1299 and A549) cells were co-cultured in a unidirectional flow bioreactor with CD8+ T-cells immobilized onto 3D-printed RGD-functionalized poly(L-lactic) acid (PLLA) scaffolds and assessed for IL-2 production. The IL-2 production was investigated for a wide range of T-cell to exosome ratios. With the successful incorporation of the RGD binding motif onto the PLLA surface at controllable densities, CD8+ T-cells were successfully attached onto 2D disks and 3D printed porous PLLA scaffolds. T-cell attachment increased with increasing RGD surface density. The diameter of the attached T-cells was 7.2 ± 0.2 µm for RGD densities below 0.5 nmoles/mm2 but dropped to 5.1 ± 0.3 µm when the RGD density was 2 nmoles/mm2 due to overcrowding. The higher the number of cancer exosomes, the less the IL-2 production by the surface-attached T-cells. In 2D disks, the IL-2 production was silenced for T-cell to exosome ratios higher than 1:10 in static conditions. IL-2 production silencing in static 3D porous scaffolds required ratios higher than 1:20. The incorporation of flow resulted in moderate to significant T-cell detachment. The portions of T-cells retained on the 3D scaffolds after exposure for 4 h to 0.15 or 1.5 mL/min of perfusion flow were 89 ± 11% and 30 ± 8%, respectively. On 3D scaffolds and in the presence of flow at 0.15 ml/min, both H1299 and A549 cancerous exosomes significantly suppressed IL-2 production for T-cell to exosome ratios of 1:1000. The much higher level of exosomes needed to silence the IL-2 production from T-cells cultured under unidirectional flow, compared to static conditions, denotes the importance of the culturing conditions and the hydrodynamic environment, on the interactions between CD8+ T-cells and cancer exosomes.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Immunotherapy and Immune Responses

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Chemical, Biological, and Materials Engineering, University of Oklahoma, Norman, OK 73019, USA

Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK 73019, USA

Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA

Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA

Funding

University of Oklahoma Institute of Biomedical Engineering Sciences and Technology

References (94)

Show source-provided references
1. A novel TP53 pathway influences the HGS-mediated exosome formation in colorectal cancer10.1038/srep28083 ↗
2. Exosomes: Looking back three decades and into the future10.1083/jcb.201212113 ↗
3. Exosomes as intercellular signalosomes and pharmacological effectors10.1016/j.bcp.2011.02.011 ↗
4. Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery10.1002/pmic.201000422 ↗
5. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences10.1038/ncomms1180 ↗
6. Microparticles: Biomarkers and beyond10.1042/CS20120309 ↗
7. Extracellular vesicle-mediated transfer of donor genomic DNA to recipient cells is a novel mechanism for genetic influence between cells10.1093/jmcb/mjt011 ↗
8. Double-stranded DNA in exosomes: A novel biomarker in cancer detection10.1038/cr.2014.44 ↗
9. Regulation of exosome release from mammary epithelial and breast cancer cells—A new regulatory pathway10.1016/j.ejca.2013.12.019 ↗
10. miR-200-containing extracellular vesicles promote breast cancer cell metastasis10.1172/JCI75695 ↗
11. Stimulating the Release of Exosomes Increases the Intercellular Transfer of Prions10.1074/jbc.M115.684258 ↗
12. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis10.1016/j.ccell.2014.09.005 ↗
13. Derailed endocytosis: An emerging feature of cancer10.1038/nrc2521 ↗
14. Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation10.1158/0008-5472.CAN-09-2470 ↗
15. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes10.1038/nbt.1807 ↗
16. Intercellular Transfer of Cancer Drug Resistance Traits by Extracellular Vesicles10.1016/j.molmed.2015.08.002 ↗
17. Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH10.1593/neo.05583 ↗
18. Chen, W.-X., Liu, X.-M., Lv, M.-M., Chen, L., Zhao, J.-H., Zhong, S.-L., Ji, M.-H., Hu, Q., Luo, Z., and Wu, J.-Z. (2014). Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. PLoS ONE, 9.10.1371/journal.pone.0095240 ↗
19. Environment-mediated drug resistance: A major contributor to minimal residual disease10.1038/nrc2714 ↗
20. Exosomes in cancer development, metastasis, and drug resistance: A comprehensive review10.1007/s10555-013-9441-9 ↗
21. Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas10.1073/pnas.0600213103 ↗
22. Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs10.1093/jnci/djh305 ↗
23. Inflammatory Immune Infiltration in Human Tumors: Role in Pathogenesis and Prognostic and Diagnostic Value
24. Immunity, inflammation, and cancer10.1016/j.cell.2010.01.025 ↗
25. Natural innate and adaptive immunity to cancer10.1146/annurev-immunol-031210-101324 ↗
26. Structure and function of major histocompatibility complex class I antigens10.1097/MOT.0b013e32833bfb33 ↗
27. Exosomal membrane molecules are potent immune response modulators10.4161/cib.3.5.12474 ↗
28. Transfer of extracellular vesicles during immune cell-cell interactions10.1111/imr.12013 ↗
29. Exosomes and cancer: A newly described pathway of immune suppression10.1158/1078-0432.CCR-10-1489 ↗
30. Exosomes: Composition, biogenesis and function10.1038/nri855 ↗
31. Malignant effusions and immunogenic tumour-derived exosomes10.1016/S0140-6736(02)09552-1 ↗
32. Exosomes as a tumor vaccine: Enhancing potency responses by extracellular vesicles10.1097/00002371-200309000-00007 ↗
33. MHC class I-mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells10.1016/S0165-2478(03)00128-7 ↗
34. Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells10.1182/blood-2008-02-142596 ↗
35. Keryer-Bibens, C., Pioche-Durieu, C., Villemant, C., Souquère, S., Nishi, N., Hirashima, M., Middeldorp, J.M., and Busson, P. (2006). Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9. BMC Cancer, 6.10.1186/1471-2407-6-283 ↗
36. Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: Role in immune escape10.1053/j.gastro.2005.03.045 ↗
37. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function10.4049/jimmunol.176.3.1375 ↗
38. Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-20310.1016/j.cellimm.2014.09.004 ↗
39. Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p10.18632/oncotarget.4924 ↗
40. Epithelial ovarian cancer-secreted exosomal miR-222-3p induces polarization of tumor-associated macrophages10.18632/oncotarget.9246 ↗
41. Optimization of cell culture conditions for exosome isolation using mini-size exclusion chromatography (mini-SEC)10.1016/j.yexcr.2019.03.014 ↗
42. Metabolic signature of extracellular vesicles depends on the cell culture conditions10.1080/20013078.2019.1596669 ↗
43. Impact of cell culture parameters on production and vascularization bioactivity of mesenchymal stem cell-derived extracellular vesicles10.1002/btm2.10065 ↗
44. Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis10.1182/bloodadvances.2016003251 ↗
45. Exosome: Function and Role in Cancer Metastasis and Drug Resistance10.1177/1533033818763450 ↗
46. In vitro Models and On-Chip Systems: Biomaterial Interaction Studies with Tissues Generated Using Lung Epithelial and Liver Metabolic Cell Lines10.3389/fbioe.2018.00120 ↗
47. In vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform10.3389/fbioe.2016.00012 ↗
48. Computational toxicology: Framework, partnerships, and program development. September 29–30, 2003, Research Triangle Park, North Carolina
49. Cell Migration and Invasion assays as tools for drug discovery10.3390/pharmaceutics3010107 ↗
50. The physics of cancer: The role of physical interactions and mechanical forces in metastasis10.1038/nrc3080 ↗
51. Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche10.1158/0008-5472.CAN-13-1355 ↗
52. Three-dimensional culture of human breast epithelial cells: The how and the why10.1007/978-1-62703-125-7_13 ↗
53. A Review of Cell Adhesion Studies for Biomedical and Biological Applications10.3390/ijms160818149 ↗
54. On the potential for fibronectin/phosphorylcholine coatings on PTFE substrates to jointly modulate endothelial cell adhesion and hemocompatibility properties10.4161/21592535.2014.979679 ↗
55. Simple coating with fibronectin fragment enhances stainless steel screw osseointegration in healthy and osteoporotic rats10.1016/j.biomaterials.2015.06.025 ↗
56. Metastatic State of Cancer Cells May Be Indicated by Adhesion Strength10.1016/j.bpj.2016.12.038 ↗
57. Bioactive polymeric scaffolds for tissue engineering
58. Signaling mechanism of cell adhesion molecules in breast cancer metastasis: Potential therapeutic targets10.1007/s10549-011-1499-x ↗
59. Modeling tumor microenvironments using custom-designed biomaterial scaffolds10.1016/j.coche.2016.01.012 ↗
60. Cancer cell lines as genetic models of their parent histology: Analyses based on array comparative genomic hybridization10.1158/0008-5472.CAN-06-3674 ↗
61. Choosing the right cell line for breast cancer research10.1186/bcr2889 ↗
62. Evaluating cell lines as tumour models by comparison of genomic profiles10.1038/ncomms3126 ↗
63. Cancer Genome Atlas Research Network, Weinstein, J.N., Collisson, E.A., Mills, G.B., Shaw, K.R., Ozenberger, B.A., Ellrott, K., Shmulevich, I., Sander, C., and Stuart, J.M. (2013). The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet., 45, 1113–1120.10.1038/ng.2764 ↗
64. A simple and fast microfluidic approach of same-single-cell analysis (SASCA) for the study of multidrug resistance modulation in cancer cells10.1039/c0lc00626b ↗
65. Microfluidic tools for cell biological research10.1016/j.nantod.2009.12.001 ↗
66. A micro cell culture analog (microCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs10.1039/b901377f ↗
67. Microfluidic: An innovative tool for efficient cell sorting10.1016/j.ymeth.2012.07.002 ↗
68. Hydrogels in regenerative medicine10.1002/adma.200802106 ↗
69. The famous versus the inconvenient—or the dawn and the rise of 3D-culture systems10.4252/wjsc.v1.i1.43 ↗
70. Towards personalized medicine with a three-dimensional micro-scale perfusion-based two-chamber tissue model system10.1016/j.biomaterials.2012.02.054 ↗
71. Putting tumours in context10.1038/35094059 ↗
72. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene10.1016/S0968-0004(98)01343-7 ↗
73. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells10.1083/jcb.139.7.1861 ↗
74. Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function10.1073/pnas.1210182109 ↗
75. From the cellular perspective: Exploring differences in the cellular baseline in macroscale and microfluidic cultures10.1039/b814565b ↗
76. Bioreactor-engineered cancer tissue-like structures mimic phenotypes, gene expression profiles and drug resistance patterns observed “in vivo”10.1016/j.biomaterials.2015.05.037 ↗
77. Biomechanical forces in tissue engineered tumor models10.1016/j.cobme.2018.03.004 ↗
78. Flow perfusion effects on three-dimensional culture and drug sensitivity of Ewing sarcoma10.1073/pnas.1506684112 ↗
79. Improved mesenchymal stem cell seeding on RGD-modified poly(L-lactic acid) scaffolds using flow perfusion10.1002/mabi.200600280 ↗
80. Enhanced osteoblastic differentiation of mesenchymal stem cells seeded in RGD-functionalized PLLA scaffolds and cultured in a flow perfusion bioreactor10.1002/term.338 ↗
81. Felder, M., Williams, C., and Sikavitsas, V. (2017). Effects of 3D Printing on Flow-Induced Shear Distributions. Tissue Engineering Part A, Mary Ann Liebert, Inc.10.3390/fluids3020025 ↗
82. Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds10.1016/S0142-9612(00)00280-5 ↗
83. Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells10.1038/srep38541 ↗
84. Effector and Regulatory T Cells Roll at High Shear Stress by Inducible Tether and Sling Formation10.1016/j.celrep.2017.11.099 ↗
85. Bioactive hydrogel substrates: Probing leukocyte receptor-ligand interactions in parallel plate flow chamber studies10.1007/s10439-006-9173-x ↗
86. Crawling of effector T cells on extracellular matrix: Role of integrins in interstitial migration in inflamed tissues10.1038/cmi.2013.47 ↗
87. Microfluidic squeezing for intracellular antigen loading in polyclonal B-cells as cellular vaccines10.1038/srep10276 ↗
88. Williams, C., Kadri, O.E., Voronov, R.S., and Sikavitsas, V.I. (2018). Time-Dependent Shear Stress Distributions during Extended Flow Perfusion Culture of Bone Tissue Engineered Constructs. Fluids, 3.10.3390/fluids3020025 ↗
89. Computational modeling of flow-induced shear stresses within 3D salt-leached porous scaffolds imaged via micro-CT10.1016/j.jbiomech.2010.01.007 ↗
90. Tumor exosomes block dendritic cells maturation to decrease the T cell immune response10.1016/j.imlet.2018.05.002 ↗
91. Clinical Significance of PD-L1(+) Exosomes in Plasma of Head and Neck Cancer Patients10.1158/1078-0432.CCR-17-2664 ↗
92. Single exosome study reveals subpopulations distributed among cell lines with variability related to membrane content10.3402/jev.v4.28533 ↗
93. Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells10.1038/s41598-019-56542-4 ↗
94. T-Cell Mechanobiology: Force Sensation, Potentiation, and Translation10.3389/fphy.2019.00045 ↗